LSTA — Lisata Therapeutics Share News
0.000.00%
- $10.91m
- $0.22m
- $0.17m
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco
U.S. STOCKS ON THE MOVE-Expeditors International, Waters, Wayfair
U.S. STOCKS ON THE MOVE-Zebra Technologies, Pfizer, Cummins
Lisata Therapeutics falls after merger collapse prompts deep job cuts
Brief: Lisata Therapeutics - On Aug 3, Approved Reduction In Workforce By About 72% Effective Immediately - SEC Filing
Brief: Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing
U.S. STOCKS ON THE MOVE-Duke Robotics, Tesla, Hasbro
Lisata tumbles as buyer Kuva fails to fund takeover on time
Brief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal
NASDAQ RESUMED AT 07:30 AM
Brief: Lisata Therapeutics To Be Acquired By Kuva Labs For $4.00 Per Share In An All-Cash Tender Offer
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM